{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:22:21Z","timestamp":1768216941056,"version":"3.49.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Porto-sinusoidal vascular disorder (PSVD) is a rare vascular liver disease that has similar manifestations to liver cirrhosis. However, limited information is available on the prevalence and clinical impacts of sarcopenia in patients with PSVD in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We enrolled 92 patients with PSVD from West China Hospital between January 2019 to June 2024 to analyze and characterize the burden of sarcopenia. The psoas muscle mass index (PMI), measured at the third lumbar vertebra (L3-PMI, cm\n                      <jats:sup>2<\/jats:sup>\n                      \/m\n                      <jats:sup>2<\/jats:sup>\n                      ), was used for quantitative analysis of skeletal muscle mass. Age- and sex- specific cut-off values, optimized for the Chinese population, were endorsed for the diagnosis of sarcopenia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sarcopenia was observed in 17 out of the 92 PSVD patients (18.5%). The sarcopenia group had a higher proportion of patients with a history of esophagogastric variceal bleeding (EGVB) compared to the non-sarcopenia group (88.24% vs. 60.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.046). Transjugular intrahepatic portosystemic shunt (TIPS) creation significantly increased L3-PMI [4.84 (3.70\u20135.44) vs. 5.10 (4.40\u20136.10),\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.0153]. During the 1-year follow-up after endoscopic treatment, the cumulative incidence of rebleeding was significantly higher in the sarcopenia group than in the non-sarcopenia group [HR 4.39, 95% CI 1.01\u201319.10, log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.0485]. Multivariate Cox regression analysis showed that sarcopenia was an independent predictor of 1-year variceal rebleeding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sarcopenia is common in patients with PSVD, particularly among those with a history of EGVB. TIPS placement may potentially enhance the muscle mass of PSVD patients. Importantly, sarcopenia appears to negatively impact clinical outcomes in PSVD patients undergoing endoscopic therapy for variceal bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1756842","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:10:44Z","timestamp":1768205444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical relevance of sarcopenia in Chinese patients with porto-sinusoidal vascular disorder"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiaxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaijie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cld.2011.12.009","article-title":"Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses","volume":"16","author":"Periyalwar","year":"2012","journal-title":"Clin Liver Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle wasting is associated with mortality in patients with cirrhosis","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","article-title":"Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis","volume":"76","author":"Tantai","year":"2022","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jhep.2024.07.035","article-title":"Porto-sinusoidal vascular liver disorder with portal hypertension: natural history and long-term outcome","volume":"82","author":"Magaz","year":"2025","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2349180","DOI":"10.1080\/07853890.2024.2349180","article-title":"Impact of sarcopenia on variceal rebleeding in patients after endoscopic therapy: a multicenter retrospective cohort study based on propensity score matching","volume":"56","author":"Liu","year":"2024","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102459","DOI":"10.1016\/j.clinre.2024.102459","article-title":"Effect of sarcopenia on liver cirrhosis with complicating oesophageal and gastric varices after endoscopic therapy","volume":"48","author":"Hao","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1148\/radiol.211172","article-title":"Sarcopenia in patients with cirrhosis after Transjugular intrahepatic portosystemic shunt placement","volume":"303","author":"Liu","year":"2022","journal-title":"Radiology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and Management of Ascites, spontaneous bacterial peritonitis and Hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1033831","DOI":"10.3389\/fnut.2022.1033831","article-title":"Age-specific reference values for low psoas muscle index at the L3 vertebra level in healthy populations: a multicenter study","volume":"9","author":"Kong","year":"2022","journal-title":"Front Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s11427-023-2619-7","article-title":"Prevalence of malnutrition among adult inpatients in China: a nationwide cross-sectional study","volume":"68","author":"Liu","year":"2025","journal-title":"Sci China Life Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1111\/liv.14160","article-title":"Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension","volume":"39","author":"Lattanzi","year":"2019","journal-title":"Liver Int"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jcsm.12349","article-title":"Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis","volume":"9","author":"Ebadi","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"EASL clinical practice guidelines on TIPS","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/apt.15186","article-title":"TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis","volume":"49","author":"Lv","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"100717","DOI":"10.1016\/j.jhepr.2023.100717","article-title":"Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: results of a randomised controlled trial","volume":"5","author":"Escorsell","year":"2023","journal-title":"JHEP Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e223201","DOI":"10.1148\/radiol.223201","article-title":"Small-diameter Transjugular intrahepatic portosystemic shunt versus endoscopic variceal ligation plus propranolol for variceal Rebleeding in advanced cirrhosis","volume":"308","author":"Wang","year":"2023","journal-title":"Radiology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + \u03b2-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","article-title":"Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China","volume":"12","author":"Zeng","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia is risk factor for development of hepatic encephalopathy after Transjugular intrahepatic portosystemic shunt placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/meg.0000000000002391","article-title":"Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt","volume":"34","author":"Bai","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/liv.14758","article-title":"Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension","volume":"41","author":"Paternostro","year":"2021","journal-title":"Liver Int"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1756842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:10:45Z","timestamp":1768205445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1756842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":27,"alternative-id":["10.3389\/fmed.2025.1756842"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1756842","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1756842"}}